Patricia Omowunmi Ayanbadejo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Patricia Omowunmi Ayanbadejo has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ayodele Charles Ogundana
Department of Periodontology and Community Dentistry, Faculty of Dental Sciences, College of Medicine University of Lagos Idi‐araba Lagos Nigeria
1 shared publication - Babatunde Yusuf Alli
Independent Researcher Ottawa Ontario Canada
1 shared publication - Ismo Tapani Räisänen
Department of Oral and Maxillofacial Diseases University of Helsinki and Helsinki University Hospital Helsinki Finland
1 shared publication - Kehinde Adesola Umeizudike
Department of Preventive Dentistry, Faculty of Dental Sciences, College of Medicine, University of Lagos, Lagos, Nigeria
1 shared publication - Olayiwola Ibrahim Olaoye
Department of Preventive Dentistry, Lagos State University Teaching Hospital, Ikeja, Lagos 100271, Nigeria
1 shared publication - Olufemi Fasanmade
Department of Medicine, Faculty of Clinical Sciences, College of Medicine University of Lagos Idi‐araba Lagos Nigeria
1 shared publication
Latest Publications
- Open Access
- 15 September 2026
- Published by Wiley in Oral Diseases
Periodontal Therapy–Related Changes in Clinical Parameters, Active‐Matrix Metalloproteinase‐8 and C‐Reactive Protein in Prediabetes and Diabetes
Objectives: This study investigated the effect of nonsurgical periodontal therapy (NSPT) on periodontal clinical parameters, active‐matrix metalloproteinase‐8 (aMMP‐8), high sensitivity C‐reactive protein (hsCRP), and glycated hemoglobin (HbA1c), and their relationships in diabetes and prediabetes patients with periodontitis. Materials and Methods: In this prospective single‐arm, interventional (before‐and‐after) study, 77 Nigerian periodontitis patients with diabetes ( n = 45) and prediabetes ( n = 32) received NSPT. Clinical parameters [periodontal inflamed surface area (PISA), Plaque Index (PLI), Gingival Index (GI)], mouthrinse aMMP‐8, serum hsCRP, and HbA1c were measured at baseline and 3 months posttreatment. Analyses included paired t ‐tests, Pearson correlation, and linear mixed effect models ( p < 0.05). Results: Diabetes and prediabetes patients showed improvements in PISA, PLI, GI, aMMP‐8, HbA1c ( p < 0.001), and hsCRP ( p = 0.001) 3 months post‐NSPT. Diabetes patients maintained improvements, but hsCRP and HbA1c were insignificant in prediabetes. Diabetes participants had greater HbA1c reduction (−0.78%), while prediabetes participants had larger aMMP‐8 decrease (−20.91 ng/mL). Obesity reduced aMMP‐8 and PLI responses, with no sex effect. Several variables showed significant correlations. Conclusion: NSPT reduces systemic inflammation and improves glycemic control, particularly in diabetes. HbA1c responds best in diabetes, aMMP‐8 in prediabetes. Mouthrinse aMMP‐8 PoC test enables real‐time periodontal monitoring and supports diabetes risk screening in dental and medical care. Trial Registration: The registration number: PACTR202608587329540; Trial registry: Pan African Clinical Trials Registry (PACTR)
- 15 September 2026
- Published by Wiley in Oral Diseases
Open AccessPeriodontal Therapy–Related Changes in Clinical Parameters, Active‐Matrix Metalloproteinase‐8 and C‐Reactive Protein in Prediabetes and Diabetes
Objectives: This study investigated the effect of nonsurgical periodontal therapy (NSPT) on periodontal clinical parameters, active‐matrix metalloproteinase‐8 (aMMP‐8), high sensitivity C‐reactive protein (hsCRP), and glycated hemoglobin (HbA1c), and their relationships in diabetes and prediabetes patients with periodontitis. Materials and Methods: In this prospective single‐arm, interventional (before‐and‐after) study, 77 Nigerian periodontitis patients with diabetes ( n = 45) and prediabetes ( n = 32) received NSPT. Clinical parameters [periodontal inflamed surface area (PISA), Plaque Index (PLI), Gingival Index (GI)], mouthrinse aMMP‐8, serum hsCRP, and HbA1c were measured at baseline and 3 months posttreatment. Analyses included paired t ‐tests, Pearson correlation, and linear mixed effect models ( p < 0.05). Results: Diabetes and prediabetes patients showed improvements in PISA, PLI, GI, aMMP‐8, HbA1c ( p < 0.001), and hsCRP ( p = 0.001) 3 months post‐NSPT. Diabetes patients maintained improvements, but hsCRP and HbA1c were insignificant in prediabetes. Diabetes participants had greater HbA1c reduction (−0.78%), while prediabetes participants had larger aMMP‐8 decrease (−20.91 ng/mL). Obesity reduced aMMP‐8 and PLI responses, with no sex effect. Several variables showed significant correlations. Conclusion: NSPT reduces systemic inflammation and improves glycemic control, particularly in diabetes. HbA1c responds best in diabetes, aMMP‐8 in prediabetes. Mouthrinse aMMP‐8 PoC test enables real‐time periodontal monitoring and supports diabetes risk screening in dental and medical care. Trial Registration: The registration number: PACTR202608587329540; Trial registry: Pan African Clinical Trials Registry (PACTR)